Stock AnalizUnitedHealth Group (UNH) earnings for the quarter ended September 2026: EPS beats estimates
UnitedHealth Group reported results for the quarter ended September 2026 on October 13, 2026. Adjusted earnings per share came in at $4.69 against the analysts’ average forecast of $4.14, a beat of 13.3%.
Revenue for the quarter was $112.69 billion, down 0.4% from $113.16 billion in the same quarter a year earlier.
The market’s verdict: the stock fell 0.2% on the first trading day after the report.
The last four quarters
UnitedHealth Group has beaten the analysts’ EPS forecast in 3 of the last 4 quarters.
| Quarter | EPS | Forecast | Surprise | Revenue growth | Price reaction |
|---|---|---|---|---|---|
| Sep 2026 | $4.69 | $4.14 | +13.3% | −0% | −0.2% |
| Jun 2026 | $6.38 | $4.92 | +29.8% | +0% | +1.8% |
| Mar 2026 | $7.23 | $6.60 | +9.5% | +2% | +9.3% |
| Dec 2025 | $2.11 | $2.11 | +0.2% | +12% | −16.4% |
What comes next
Analysts expect EPS of $2.27 for the next quarter on average and $20.52 for the fiscal year ending December 31, 2026.
The average analyst price target is $476.16, 17% above the current price of $407.46.
Valuation and score
UnitedHealth Group scores 3.0 out of 5 overall on Stock Analiz (good, with some weak spots), trades at a trailing P/E of about 23.3, and its intrinsic value under moderate assumptions is about 1% above the current market value. Full UnitedHealth Group analysis with 10 years of financials
Frequently asked questions
What was UnitedHealth Group’s EPS for the quarter ended September 2026?
$4.69 adjusted per share, against an analyst consensus of $4.14.
How much revenue did UnitedHealth Group report?
$112.69 billion, down 0.4% year over year.
More
This report was written automatically from the published numbers within hours of the release. It is information, not investment advice.